Th17 cell cytokine secretion profile in host defense and autoimmunity

Inflammation Research

Volumn 61, Issue 2, 2012, Pages 87-96

  Graeber, Kristen E ^a   Olsen, Nancy J ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Autoimmune disease; Chemokines; Cytokines; Interleukin 17; T effector cells; Th17 cells

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 26; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; CELL FUNCTION; CROHN DISEASE; CYTOKINE RELEASE; ENCEPHALITIS; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TH17 CELL; ULCERATIVE COLITIS;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BACTERIAL INFECTIONS; CYTOKINES; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; MALE; MICE; MYCOSES; TH17 CELLS;

EID: 84857578521     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-011-0419-1     Document Type: Review

References (97)

1. AK Abbas KM Murphy A Sher 1996 Functional diversity of helper T lymphocytes Nature 383 787 793 8893001 10.1038/383787a0 1:CAS:528: DyaK28XmsF2qsLY%3D (Pubitemid 26372655)
2. SJ Szabo BM Sullivan SL Peng LH Glimcher 2003 Molecular mechanisms regulating Th1 immune responses Annu Rev Immunol 21 713 758 12500979 10.1146/annurev.immunol.21.120601.140942 1:CAS:528:DC%2BD3sXjtF2is7k%3D (Pubitemid 37174546)
3. WE Paul 2010 What determines Th2 differentiation, in vitro and in vivo? Immunol Cell Biol 88 236 239 20157328 10.1038/icb.2010.2 1:CAS:528: DC%2BC3cXjsFSksbc%3D
4. SG Zheng JD Gray K Ohtsuka S Yamagiwa DA Horwitz 2002 Generation ex vivo of TGF-beta-producing regulatory T cells from CD4 + CD25- precursors J Immunol 169 4183 4189 12370347 1:CAS:528:DC%2BD38XnvFGntLg%3D (Pubitemid 35178188)
5. SZ Josefowicz A Rudensky 2009 Control of regulatory T cell lineage commitment and maintenance Immunity 30 616 625 19464984 10.1016/j.immuni.2009. 04.009 1:CAS:528:DC%2BD1MXosVCks7o%3D
6. S Sakaguchi N Sakaguchi M Asano M Itoh M Toda 1995 Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25) Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 1151 1164 1:CAS:528: DyaK2MXntFWnurs%3D
7. W Lin N Truong WJ Grossman D Haribhai CB Williams J Wang, et al. 2005 Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice J Allergy Clin Immunol 116 1106 1115 16275384 10.1016/j.jaci.2005.08.046 1:CAS:528:DC%2BD2MXht1WjtbjM (Pubitemid 41571796)
8. S Romagnani 1994 Lymphokine production by human T cells in disease states Annu Rev Immunol 12 227 257 8011282 10.1146/annurev.iy.12.040194.001303 1:CAS:528:DyaK2cXivFKju78%3D
9. LE Harrington RD Hatton PR Mangan H Turner TL Murphy KM Murphy, et al. 2005 Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages Nat Immunol 6 1123 1132 16200070 10.1038/ni1254 1:CAS:528:DC%2BD2MXhtFamsb7J (Pubitemid 41541790)
10. H Park Z Li XO Yang SH Chang R Nurieva YH Wang, et al. 2005 A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 Nat Immunol 6 1133 1141 16200068 10.1038/ni1261 1:CAS:528:DC%2BD2MXhtFamsb%2FO (Pubitemid 41541791)
11. DJ Cua J Sherlock Y Chen CA Murphy B Joyce B Seymour, et al. 2003 Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain Nature 421 744 748 12610626 10.1038/nature01355 1:CAS:528:DC%2BD3sXhsV2rsbs%3D (Pubitemid 36227625)
12. S Aggarwal N Ghilardi MH Xie FJ de Sauvage AL Gurney 2003 Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 J Biol Chem 278 1910 1914 12417590 10.1074/jbc.M207577200 1:CAS:528:DC%2BD3sXisFyksA%3D%3D (Pubitemid 36801431)
13. Y Sha S Markovic-Plese 2011 A role of IL-1R1 signaling in the differentiation of Th17 cells and the development of autoimmune diseases Self Nonself 2 35 42 21776333
14. C Lamacchia G Palmer CA Seemayer D Talabot-Ayer C Gabay 2010 Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist Arthritis Rheum 62 452 462 20112392 1:CAS:528:DC%2BC3cXhtFGnu7%2FL
15. J Zhu WE Paul 2010 Heterogeneity and plasticity of T helper cells Cell Res 20 4 12 20010916 10.1038/cr.2009.138
16. G Beriou EM Bradshaw E Lozano CM Costantino WD Hastings T Orban, et al. 2010 TGF-beta induces IL-9 production from human Th17 cells J Immunol 185 46 54 20498357 10.4049/jimmunol.1000356 1:CAS:528:DC%2BC3cXns1CqsLs%3D
17. R Nurieva XO Yang G Martinez Y Zhang AD Panopoulos L Ma, et al. 2007 Essential autocrine regulation by IL-21 in the generation of inflammatory T cells Nature 448 480 483 17581589 10.1038/nature05969 1:CAS:528: DC%2BD2sXotFajur8%3D (Pubitemid 47123514)
18. NJ Wilson K Boniface JR Chan BS McKenzie WM Blumenschein JD Mattson, et al. 2007 Development, cytokine profile and function of human interleukin 17-producing helper T cells Nat Immunol 8 950 957 17676044 10.1038/ni1497 1:CAS:528:DC%2BD2sXptlSku7o%3D (Pubitemid 47300009)
19. F Annunziato L Cosmi V Santarlasci L Maggi F Liotta B Mazzinghi, et al. 2007 Phenotypic and functional features of human Th17 cells J Exp Med 204 1849 1861 17635957 10.1084/jem.20070663 1:CAS:528:DC%2BD2sXptVyjsLs%3D (Pubitemid 47240944)
20. A Peck ED Mellins 2010 Precarious balance: Th17 cells in host defense Infect Immun 78 32 38 19901061 10.1128/IAI.00929-09 1:CAS:528: DC%2BC3cXhtFaitbg%3D
21. LA Zenewicz GD Yancopoulos DM Valenzuela AJ Murphy M Karow RA Flavell 2007 Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation Immunity 27 647 659 17919941 10.1016/j.immuni.2007.07.023 1:CAS:528:DC%2BD2sXht1ygurzK (Pubitemid 47615503)
22. Y Zheng DM Danilenko P Valdez I Kasman J Eastham-Anderson J Wu, et al. 2007 Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis Nature 445 648 651 17187052 10.1038/nature05505 1:CAS:528:DC%2BD2sXhtlOrtLk%3D (Pubitemid 46232884)
23. BR Marks HN Nowyhed JY Choi AC Poholek JM Odegard RA Flavell, et al. 2009 Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation Nat Immunol 10 1125 1132 19734905 10.1038/ni.1783 1:CAS:528:DC%2BD1MXhtV2gsbrF
24. K Sugimoto A Ogawa E Mizoguchi Y Shimomura A Andoh AK Bhan, et al. 2008 IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis J Clin Invest 118 534 544 18172556 1:CAS:528:DC%2BD1cXhsFOmsr8%3D (Pubitemid 351206544)
25. SG Hymowitz EH Filvaroff JP Yin J Lee L Cai P Risser, et al. 2001 IL-17 s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding EMBO J 20 5332 5341 11574464 10.1093/emboj/20.19.5332 1:CAS:528:DC%2BD38XjtVSrug%3D%3D (Pubitemid 32959452)
26. P Ye FH Rodriguez S Kanaly KL Stocking J Schurr P Schwarzenberger, et al. 2001 Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense J Exp Med 194 519 527 11514607 10.1084/jem.194.4.519 1:CAS:528:DC%2BD3MXmt1egu7o%3D (Pubitemid 32835046)
27. Z Yao WC Fanslow MF Seldin AM Rousseau SL Painter MR Comeau, et al. 1995 Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor Immunity 3 811 821 8777726 10.1016/1074-7613(95)90070-5 1:CAS:528:DyaK28XhtF2gsw%3D%3D (Pubitemid 26091152)
28. Z Yao SL Painter WC Fanslow D Ulrich BM Macduff MK Spriggs, et al. 1995 Human IL-17: a novel cytokine derived from T cells J Immunol 155 5483 5486 7499828 1:CAS:528:DyaK2MXpvVertbk%3D
29. JK Kolls A Lindén 2004 Interleukin-17 family members and inflammation Immunity 21 467 476 15485625 10.1016/j.immuni.2004.08.018 1:CAS:528:DC%2BD2cXpvVygt7k%3D (Pubitemid 39370503)
30. JC Renauld 2003 Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators Nat Rev Immunol 3 667 676 12974481 10.1038/nri1153 1:CAS:528:DC%2BD3sXntV2rs7Y%3D
31. K Wolk E Witte U Reineke K Witte M Friedrich W Sterry, et al. 2005 Is there an interaction between interleukin-10 and interleukin-22? Genes Immun 6 8 18 15526001 10.1038/sj.gene.6364224 1:CAS:528:DC%2BD2MXnt1WhtQ%3D%3D (Pubitemid 43090523)
32. LA Zenewicz GD Yancopoulos DM Valenzuela AJ Murphy S Stevens RA Flavell 2008 Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease Immunity 29 947 957 19100701 10.1016/j.immuni.2008.11.003 1:CAS:528:DC%2BD1MXhtlymtQ%3D%3D
33. K Wolk S Kunz E Witte M Friedrich K Asadullah R Sabat 2004 IL-22 increases the innate immunity of tissues Immunity 21 241 254 15308104 10.1016/j.immuni.2004.07.007 1:CAS:528:DC%2BD2cXnsVKlt7k%3D (Pubitemid 39094053)
34. K Boniface FX Bernard M Garcia AL Gurney JC Lecron F Morel 2005 IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes J Immunol 174 3695 3702 15749908 1:CAS:528:DC%2BD2MXitVeht7Y%3D (Pubitemid 40354080)
35. S Brand J Dambacher F Beigel K Zitzmann MH Heeg TS Weiss, et al. 2007 IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro Am J Physiol Gastrointest Liver Physiol 292 G1019 G1028 17204547 10.1152/ajpgi.00239.2006 1:CAS:528:DC%2BD2sXks1Kjsbc%3D (Pubitemid 46557789)
36. H Pan F Hong S Radaeva B Gao 2004 Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3 Cell Mol Immunol 1 43 49 16212920 1:CAS:528:DC%2BD2cXmvF2rsb0%3D
37. S Radaeva R Sun HN Pan F Hong B Gao 2004 Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation Hepatology 39 1332 1342 15122762 10.1002/hep.20184 1:CAS:528:DC%2BD2cXks1Sjtbo%3D (Pubitemid 38569055)
38. S Eyerich K Eyerich D Pennino T Carbone F Nasorri S Pallotta, et al. 2009 Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling J Clin Invest 119 3573 3585 19920355 1:CAS:528:DC%2BD1MXhsFCit7jP
39. WJ Leonard R Spolski 2005 Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation Nat Rev Immunol 5 688 698 16138102 10.1038/nri1688 1:CAS:528:DC%2BD2MXpslakurY%3D (Pubitemid 43086171)
40. R Spolski WJ Leonard 2008 Interleukin-21: basic biology and implications for cancer and autoimmunity Annu Rev Immunol 26 57 79 17953510 10.1146/annurev.immunol.26.021607.090316 1:CAS:528:DC%2BD1cXltlWksLc%3D (Pubitemid 351600371)
41. L Wei A Laurence KM Elias JJ O'Shea 2007 IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner J Biol Chem 282 34605 34610 17884812 10.1074/jbc.M705100200 1:CAS:528:DC%2BD2sXhtlCrtrrI (Pubitemid 350232469)
42. R Ettinger GP Sims AM Fairhurst R Robbins YS da Silva R Spolski, et al. 2005 IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells J Immunol 175 7867 7879 16339522 1:CAS:528:DC%2BD2MXht12jtrfO (Pubitemid 41798347)
43. K Ozaki R Spolski CG Feng CF Qi J Cheng A Sher, et al. 2002 A critical role for IL-21 in regulating immunoglobulin production Science 298 1630 1634 12446913 10.1126/science.1077002 1:CAS:528:DC%2BD38Xosl2kurc%3D (Pubitemid 35387203)
44. S Hör H Pirzer L Dumoutier F Bauer S Wittmann H Sticht, et al. 2004 The T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chains J Biol Chem 279 33343 33351 15178681 10.1074/jbc.M405000200 (Pubitemid 39062982)
45. J Dambacher F Beigel K Zitzmann EN De Toni B Göke HM Diepolder, et al. 2009 The role of the novel Th17 cytokine IL-26 in intestinal inflammation Gut 58 1207 1217 18483078 10.1136/gut.2007.130112 1:CAS:528:DC%2BD1MXht1Wns7rF
46. E Schmitt T Germann S Goedert P Hoehn C Huels S Koelsch, et al. 1994 IL-9 production of naive CD4 + T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma J Immunol 153 3989 3996 7930607 1:CAS:528:DyaK2cXmsFent74%3D
47. EC Nowak CT Weaver H Turner S Begum-Haque B Becher B Schreiner, et al. 2009 IL-9 as a mediator of Th17-driven inflammatory disease J Exp Med 206 1653 1660 19596803 10.1084/jem.20090246 1:CAS:528:DC%2BD1MXps1enurs%3D
48. GL Stephens B Swerdlow E Benjamin AJ Coyle A Humbles R Kolbeck, et al. 2011 IL-9 is a Th17-derived cytokine that limits pathogenic activity in organ-specific autoimmune disease Eur J Immunol 41 952 962 21360526 10.1002/eji.201040879 1:CAS:528:DC%2BC3MXjslCmsLw%3D
49. H Faulkner N Humphreys JC Renauld J Van Snick R Grencis 1997 Interleukin-9 is involved in host protective immunity to intestinal nematode infection Eur J Immunol 27 2536 2540 9368607 10.1002/eji.1830271011 1:CAS:528:DyaK2sXmvFanu78%3D (Pubitemid 27453841)
50. JM Townsend GP Fallon JD Matthews P Smith EH Jolin NA McKenzie 2000 IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development Immunity 13 573 583 11070175 10.1016/S1074-7613(00)00056-X 1:CAS:528:DC%2BD3cXnsl2nt7o%3D
51. EE Forbes K Groschwitz JP Abonia EB Brandt E Cohen C Blanchard, et al. 2008 IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity J Exp Med 205 897 913 18378796 10.1084/jem.20071046 1:CAS:528:DC%2BD1cXkvVyrs78%3D (Pubitemid 351549886)
52. R Goswami MH Kaplan 2011 A brief history of IL-9 J Immunol 186 3283 3288 21368237 10.4049/jimmunol.1003049 1:CAS:528:DC%2BC3MXisl2qsLY%3D
53. M Baba T Imai M Nishimura M Kakizaki S Takagi K Hieshima, et al. 1997 Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC J Biol Chem 272 14893 14898 9169459 10.1074/jbc.272.23.14893 1:CAS:528:DyaK2sXjslektr4%3D (Pubitemid 27251760)
54. K Hirota H Yoshitomi M Hashimoto S Maeda S Teradaira N Sugimoto, et al. 2007 Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model J Exp Med 204 2803 2812 18025126 10.1084/jem.20071397 1:CAS:528:DC%2BD2sXhsVSgs7zK (Pubitemid 350179551)
55. C Lock G Hermans R Pedotti A Brendolan E Schadt H Garren, et al. 2002 Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis Nat Med 8 500 508 11984595 10.1038/nm0502-500 1:CAS:528:DC%2BD38Xjt1Kgur8%3D (Pubitemid 34546753)
56. L Steinman 2007 A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage Nat Med 13 139 145 17290272 10.1038/nm1551 1:CAS:528:DC%2BD2sXhsVykuro%3D
57. CL Langrish Y Chen WM Blumenschein J Mattson B Basham JD Sedgwick, et al. 2005 IL-23 drives a pathogenic T cell population that induces autoimmune inflammation J Exp Med 201 233 240 15657292 10.1084/jem.20041257 1:CAS:528:DC%2BD2MXot12mtA%3D%3D (Pubitemid 40189432)
58. CJ Hedegaard M Krakauer K Bendtzen H Lund F Sellebjerg CH Nielsen 2008 T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis Immunology 125 161 169 18397264 10.1111/j.1365-2567.2008.02837.x 1:CAS:528:DC%2BD1cXht1ansr3L
59. M Montes X Zhang L Berthelot DA Laplaud S Brouard J Jin, et al. 2009 Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells Clin Immunol 130 133 144 18977698 10.1016/j.clim.2008.08.030 1:CAS:528:DC%2BD1MXht1aksg%3D%3D
60. E Lubberts LA Joosten B Oppers L van den Bersselaar CJ Coenen-de Roo JK Kolls, et al. 2001 IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis J Immunol 167 1004 1013 11441109 1:CAS:528:DC%2BD3MXotFWktLk%3D (Pubitemid 32660858)
61. JP van Hamburg PS Asmawidjaja N Davelaar AM Mus EM Colin JM Hazes, et al. 2011 Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production Arthritis Rheum 63 73 83 20954258 10.1002/art.30093
62. E Lubberts 2008 IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis? Cytokine 41 84 91 18039580 10.1016/j.cyto.2007.09.014 1:CAS:528:DC%2BD1cXhsl2gt7c%3D
63. P Miossec 2011 IL-17 and Th17 cells: From adult to juvenile arthritis now it is serious! Arthritis Rheum 63 2168 2171 21380999 10.1002/art.30331 1:CAS:528:DC%2BC3MXpsFejt7s%3D
64. W Shen SK Durum 2010 Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease Neurochem Res 35 940 946 19915978 10.1007/s11064-009-0091-9 1:CAS:528:DC%2BD1MXhsVWmsLzE
65. D Yen J Cheung H Scheerens F Poulet T McClanahan B McKenzie, et al. 2006 IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6 J Clin Invest 116 1310 1316 16670770 10.1172/JCI21404 1:CAS:528:DC%2BD28XksVWns78%3D
66. S Fujino A Andoh S Bamba A Ogawa K Hata Y Araki, et al. 2003 Increased expression of interleukin 17 in inflammatory bowel disease Gut 52 65 70 12477762 10.1136/gut.52.1.65 1:CAS:528:DC%2BD3sXmtVyqsw%3D%3D (Pubitemid 36020767)
67. OH Nielsen I Kirman N Rüdiger J Hendel B Vainer 2003 Upregulation of interleukin-12 and -17 in active inflammatory bowel disease Scand J Gastroenterol 38 180 185 12678335 10.1080/00365520310000672 1:STN:280: DC%2BD3s7mtFWjtw%3D%3D
68. TN Lavoie CM Stewart KM Berg Y Li CQ Nguyen 2011 Expression of interleukin-22 in Sjögren's syndrome: significant correlation with disease parameters Scand J Immunol 74 377 382 21645026 10.1111/j.1365-3083.2011.02583.x 1:CAS:528:DC%2BC3MXhtlarsrvM
69. H Chang H Hanawa H Liu T Yoshida M Hayashi R Watanabe, et al. 2006 Hydrodynamic-based delivery of an interleukin-22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats J Immunol 177 3635 3643 16951323 1:CAS:528:DC%2BD28XptlOhu7k%3D (Pubitemid 44359895)
70. JM Coquet S Chakravarti MJ Smyth DI Godfrey 2008 Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis J Immunol 180 7097 7101 18490706 1:CAS:528: DC%2BD1cXmtVant7g%3D
71. JM Odegard BR Marks LD DiPlacido AC Poholek DH Kono C Dong, et al. 2008 ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity J Exp Med 205 2873 2886 18981236 10.1084/jem.20080840 1:CAS:528:DC%2BD1cXhsVClt7jO
72. LE Clough CJ Wang EM Schmidt G Booth TZ Hou GA Ryan, et al. 2008 Release from regulatory T cell-mediated suppression during the onset of tissue-specific autoimmunity is associated with elevated IL-21 J Immunol 180 5393 5401 18390721 1:CAS:528:DC%2BD1cXkt1arsbY%3D
73. JL Jones CL Phuah AL Cox SA Thompson M Ban J Shawcross, et al. 2009 IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H) J Clin Invest 119 2052 2061 19546505 1:CAS:528:DC%2BD1MXosVCrs7s%3D
74. TL Vollmer R Liu M Price S Rhodes A La Cava FD Shi 2005 Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen J Immunol 174 2696 2701 15728477 1:CAS:528:DC%2BD2MXhsFeqs74%3D (Pubitemid 40279684)
75. DA Young M Hegen HL Ma MJ Whitters LM Albert L Lowe, et al. 2007 Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis Arthritis Rheum 56 1152 1163 17393408 10.1002/art.22452 1:CAS:528:DC%2BD2sXltFKgsrY%3D (Pubitemid 46608640)
76. D Herber TP Brown S Liang DA Young M Collins K Dunussi-Joannopoulos 2007 IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression J Immunol 178 3822 3830 17339481 1:CAS:528:DC%2BD2sXisVGjtrY%3D (Pubitemid 46417651)
77. X Niu D He X Zhang T Yue N Li JZ Zhang, et al. 2010 IL-21 regulates Th17 cells in rheumatoid arthritis Hum Immunol 71 334 341 20079789 10.1016/j.humimm.2010.01.010 1:CAS:528:DC%2BC3cXjs1Wqtr4%3D
78. K Vandenbroeck S Cunningham A Goris I Alloza S Heggarty C Graham, et al. 2003 Polymorphisms in the interferon-gamma/interleukin-26 gene region contribute to sex bias in susceptibility to rheumatoid arthritis Arthritis Rheum 48 2773 2778 14558082 10.1002/art.11236 1:CAS:528:DC%2BD3sXpt1Sku7Y%3D (Pubitemid 37280605)
79. NP Singh VL Hegde LJ Hofseth M Nagarkatti P Nagarkatti 2007 Resveratrol (trans-3, 5, 4′-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor Mol Pharmacol 72 1508 1521 17872969 10.1124/mol.107.038984 1:CAS:528:DC%2BD2sXhsVagsr7F (Pubitemid 350146088)
80. H Li B Nourbakhsh B Ciric GX Zhang A Rostami 2010 Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population J Immunol 185 4095 4100 20805418 10.4049/jimmunol.1000986 1:CAS:528:DC%2BC3cXhtFyisrnN
81. W Elyaman EM Bradshaw C Uyttenhove V Dardalhon A Awasthi J Imitola, et al. 2009 IL-9 induces differentiation of TH17 cells and enhances function of FoxP3 + natural regulatory T cells Proc Natl Acad Sci USA 106 12885 12890 19433802 10.1073/pnas.0812530106 1:CAS:528:DC%2BD1MXhtVKlt7zL
82. LF Lu EF Lind DC Gondek KA Bennett MW Gleeson K Pino-Lagos, et al. 2006 Mast cells are essential intermediaries in regulatory T-cell tolerance Nature 442 997 1002 16921386 10.1038/nature05010 1:CAS:528:DC%2BD28XovVyhtb4%3D (Pubitemid 44330250)
83. B Homey MC Dieu-Nosjean A Wiesenborn C Massacrier JJ Pin E Oldham, et al. 2000 Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis J Immunol 164 6621 6632 10843722 1:CAS:528:DC%2BD3cXktFWlurY%3D (Pubitemid 30408849)
84. S Sarkar DA Fox 2010 Targeting IL-17 and Th17 cells in rheumatoid arthritis Rheum Dis Clin North Am 36 345 366 20510238 10.1016/j.rdc.2010.02.006
85. P Muranski NP Restifo 2009 Adoptive immunotherapy of cancer using CD4(+) T cells Curr Opin Immunol 21 200 208 19285848 10.1016/j.coi.2009.02.004 1:CAS:528:DC%2BD1MXlsVCgtLk%3D
86. E Ambrosini S Columba-Cabezas B Serafini A Muscella F Aloisi 2003 Astrocytes are the major intracerebral source of macrophage inflammatory protein-3alpha/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro Glia 41 290 300 12528183 10.1002/glia.10193 (Pubitemid 36258473)
87. A Reboldi C Coisne D Baumjohann F Benvenuto D Bottinelli S Lira, et al. 2009 C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE Nat Immunol 10 514 523 19305396 10.1038/ni.1716 1:CAS:528:DC%2BD1MXjsVGjs7Y%3D
88. M Chabaud JM Durand N Buchs F Fossiez G Page L Frappart, et al. 1999 Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium Arthritis Rheum 42 963 970 10323452 10.1002/1529- 0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E 1:CAS:528:DyaK1MXjtlKjurs%3D (Pubitemid 29215007)
89. R Cascão RA Moura I Perpétuo H Canhão E Vieira-Sousa AF Mourão, et al. 2010 Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis Arthritis Res Ther 12 R196 20961415 10.1186/ar3168
90. M Sarra I Monteleone C Stolfi MC Fantini P Sileri G Sica, et al. 2010 Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases Inflamm Bowel Dis 16 1332 1339 20186935 10.1002/ibd.21248
91. HJ Lee SC Choi MH Lee HM Oh EY Choi EJ Choi, et al. 2005 Increased expression of MIP-3alpha/CCL20 in peripheral blood mononuclear cells from patients with ulcerative colitis and its down-regulation by sulfasalazine and glucocorticoid treatment Inflamm Bowel Dis 11 1070 1079 16306769 10.1097/01.MIB.0000187576.26043.ac (Pubitemid 41682563)
92. MA Lowes T Kikuchi J Fuentes-Duculan I Cardinale LC Zaba AS Haider, et al. 2008 Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells J Invest Dermatol 128 1207 1211 18200064 10.1038/sj.jid.5701213 1:CAS:528:DC%2BD1cXksFyhsbs%3D (Pubitemid 351543220)
93. R Caruso E Botti M Sarra M Esposito C Stolfi L Diluvio, et al. 2009 Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis Nat Med 15 1013 1015 19684581 10.1038/nm.1995 1:CAS:528:DC%2BD1MXpvFCrtrg%3D
94. SA Apostolidis JC Crispín GC Tsokos 2011 IL-17-producing T cells in lupus nephritis Lupus 20 120 124 21303828 10.1177/0961203310389100 1:CAS:528:DC%2BC3MXjvFSntbo%3D
95. F Cheng Z Guo H Xu D Yan Q Li 2009 Decreased plasma IL22 levels, but not increased IL17 and IL23 levels, correlate with disease activity in patients with systemic lupus erythematosus Ann Rheum Dis 68 604 606 19286907 10.1136/ard.2008.097089 1:CAS:528:DC%2BD1MXkt1emtbg%3D
96. CS De Paiva CS Hwang JD Pitcher SB Pangelinan E Rahimy W Chen, et al. 2010 Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice Rheumatology (Oxford) 49 246 258 10.1093/rheumatology/kep357
97. GE Katsifis S Rekka NM Moutsopoulos S Pillemer SM Wahl 2009 Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis Am J Pathol 175 1167 1177 19700754 10.2353/ajpath.2009.090319 1:CAS:528:DC%2BD1MXhtF2isbrN